mitoquinone mesylate mitoquinone mesylate mitoquinone mesylate (mitoq) is a synthetic analogue of coenzyme q10 which has antioxidant effects. it was first developed in new zealand in the late 1990s. it has significantly improved bioavailability and improved mitochondrial penetration compared to coenzyme q10, and has shown potential in a number of medical indications, being widely sold as a dietary supplement. mitoquinone mesylateclinical datatrade namesmitoqidentifiers iupac name 10-(4,5-dimethoxy-2-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)decyl-triphenylphosphanium methanesulfonate cas number845959-50-4pubchem cid11388331chemspider9563239unii6e01cg547tchemblchembl4074884comptox dashboard (epa)dtxsid00233573 chemical and physical dataformulac38h47o7psmolar mass678.82 g·mol−13d model (jsmol)interactive image smiles cc1=c(c(=o)c(=c(c1=o)oc)oc)cccccccccc(c2=cc=cc=c2)(c3=cc=cc=c3)c4=cc=cc=c4.cs(=o)(=o) inchi inchi=1s/c37h44o4p.ch4o3s/c1-29-33(35(39)37(41-3)36(40-2)34(29)38)27-19-8-6-4-5-7-9-20-28-42(30-21-13-10-14-22-30,31-23-15-11-16-24-31)32-25-17-12-18-26-32;1-5(2,3)4/h10-18,21-26h,4-9,19-20,27-28h2,1-3h3;1h3,(h,2,3,4)/q+1;/p-1key:gvzfuvxptpgoqt-uhfffaoysa-m a 2014 review found insufficient evidence for the use of mitoquinone mesylate in parkinson's disease and other movement disorders.